TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2284577

Group type: EXPERIMENTAL
Intervention: Amikacin plus piperacillin
Number of subjects: 69

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 69
Study: 373645

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Symptomatic treatment alone
Number of subjects: 2
Study: 31110097

Group type: EXPERIMENTAL
Intervention: STOP trained staff
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untrained staff
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: NHS SSS leaflets
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trained counter staff
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Body language use
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Key phrases from STOP training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: STOP promotional badges
Number of subjects: 30
Study: 28522317

Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate
Number of subjects: 268

Group type: COMPARATOR
Intervention: CYP single nucleotide polymorphisms *22, *1G, *1B, and *3
Number of subjects: 268

Group type: COMPARATOR
Intervention: Progesterone receptor single nucleotide polymorphisms rs578029, rs471767, rs666553, rs503362, and rs500760
Number of subjects: 268
Study: 23601741

Group type: EXPERIMENTAL
Intervention: High monounsaturated fat hypocaloric diet (Diet M)
Number of subjects: 261

Group type: COMPARATOR
Intervention: High polyunsaturated fat hypocaloric diet (Diet P)
Number of subjects: 261
Study: 22108479

Group type: EXPERIMENTAL
Intervention: Pycnogenol® (100 mg daily for 8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pycnogenol®
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 19705494

Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac (75 mg loading dose) and isotonic saline infusion (5-10 mL/kg per hour over 4 hours)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (500 mL isotonic saline infusion)
Number of subjects: 80
Study: 17307303

Group type: EXPERIMENTAL
Intervention: Cigarette Dependence Scale (CDS)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Fagerstrom Test for Nicotine Dependence Scale (FTND)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Nicotine Dependence Syndrome Scale (NDSS)
Number of subjects: 700
Study: 15070908

Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4) supplementation for 7 months in cohort 1 and 11 months in cohort 2.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo for 7 months in cohort 1 and 11 months in cohort 2.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo group measurements of TSH and Tg during AR.
Number of subjects: 24
Study: 12426264

Group type: EXPERIMENTAL
Intervention: Emergency treatment for obstructive pulmonary disease
Number of subjects: 43
Study: 10442911

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 763

Group type: COMPARATOR
Intervention: Unoperated persons with normal vision
Number of subjects: 763

Group type: COMPARATOR
Intervention: Unoperated persons with visual acuity less than 0.05 in both eyes
Number of subjects: 763

Group type: COMPARATOR
Intervention: Unoperated population
Number of subjects: 763
Study: 7491853

Group type: EXPERIMENTAL
Intervention: Cu-Safe 300 IUD
Number of subjects: 600

Group type: COMPARATOR
Intervention: TCu380A IUD
Number of subjects: 600
Study: 2178599

Group type: EXPERIMENTAL
Intervention: IM ephedrine 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM scopolamine 0.1 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM dimenhydrinate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IM metoclopramide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.3 mg scopolamine
Number of subjects: 0
Study: 7424843

Group type: EXPERIMENTAL
Intervention: Microtraining
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Programmed learning
Number of subjects: 25

Group type: COMPARATOR
Intervention: No-training control
Number of subjects: 25
Study: 30595567

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 54
Study: 26178634

Group type: EXPERIMENTAL
Intervention: N-acetyl glucosamine (100 mg) and chondroitin sulfate (180 mg) daily for 24 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: N-acetyl glucosamine and chondroitin sulfate
Number of subjects: 50
Study: 24559909

Group type: EXPERIMENTAL
Intervention: Nurse facilitated, cognitive behavioural self-management programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care including un-facilitated access to the same manual
Number of subjects: 0
Study: 22281781

Group type: EXPERIMENTAL
Intervention: Local microwave diathermy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Subacromial corticosteroid injections
Number of subjects: 92
Study: 21176307

Group type: EXPERIMENTAL
Intervention: goserelin 3.6 mg one month before ablation
Number of subjects: 105

Group type: COMPARATOR
Intervention: suction curettage immediately before ablation
Number of subjects: 105
Study: 17958584

Group type: EXPERIMENTAL
Intervention: 15 U of BTX‐A reconstituted and refrigerated at 4 degrees C 1 week before application
Number of subjects: 30

Group type: COMPARATOR
Intervention: 15 U of fresh BTX‐A
Number of subjects: 30
Study: 14766487

Group type: EXPERIMENTAL
Intervention: Random practice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blocked practice
Number of subjects: 30
Study: 12630494

Group type: EXPERIMENTAL
Intervention: Fortified beverage (F)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Non-fortified beverage (NF)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 439
Study: 9743784

Group type: EXPERIMENTAL
Intervention: Intervention group (urban general practice attachment organized by project team)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard student attachment (control group)
Number of subjects: 100
Study: 8113064

Group type: EXPERIMENTAL
Intervention: CATCH PE teacher training and in-service support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring training and support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Curriculum implementation
Number of subjects: 0
Study: 3289357

Group type: EXPERIMENTAL
Intervention: APSAC (30 U intravenously over 5 minutes)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Streptokinase (250,000 IU intracoronary infusion over 90 minutes)
Number of subjects: 85
Study: 30744396

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia plus positive mood strategies (CBT-I+)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy for insomnia (CBT-I) and CBT-I+
Number of subjects: 31
Study: 30246890

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain HN001
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis strain HN019
Number of subjects: 474

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 474
Study: 27997254

Group type: EXPERIMENTAL
Intervention: Guideline adherence for COPD exacerbation treatment
Number of subjects: 378
Study: 25677074

Group type: EXPERIMENTAL
Intervention: STN 200 mg b.i.d. + standard-exposure TAC (n=50)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: STN 200 mg b.i.d. + reduced-exposure TAC (n=52)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: STN 300 mg b.i.d. + reduced-exposure TAC (n=50)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 1 g b.i.d. + standard-exposure TAC (control, n=52)
Number of subjects: 204
Study: 23334562

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 101
Study: 20559306

Group type: EXPERIMENTAL
Intervention: HI PA diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HI OA diet
Number of subjects: 24
Study: 18936478

Group type: EXPERIMENTAL
Intervention: Age-related differences in recall of information during oncology consultations
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Amount of information presented
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Prognosis information provided
Number of subjects: 260
Study: 16608929

Group type: EXPERIMENTAL
Intervention: Conventional evaluation plus spirometry
Number of subjects: 333

Group type: COMPARATOR
Intervention: Conventional evaluation alone
Number of subjects: 333
Study: 14616490

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream applied three times a week for 3 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Vehicle cream applied three times a week for 3 weeks
Number of subjects: 39
Study: 11185326

Group type: EXPERIMENTAL
Intervention: Reminder postcard
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reminder telephone call
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivational telephone call
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reminder postcard (among women with no previous mammography)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reminder telephone call (among women with no previous mammography)
Number of subjects: 0
Study: 8829162

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 222

Group type: COMPARATOR
Intervention: Sterile water mouthwash (placebo)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: PSMA program (both groups)
Number of subjects: 222
Study: 8101024

Group type: EXPERIMENTAL
Intervention: metoprolol 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 20
Study: 2946838

Group type: EXPERIMENTAL
Intervention: Increased sodium intake (NaCl 4.6 mmol/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low sodium intake (1.5 mmol/kg/d)
Number of subjects: 0
Study: 29893477

Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet rich fibrin (T-PRF)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Allografts
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: T-PRF
Number of subjects: 18
Study: 28028979

Group type: EXPERIMENTAL
Intervention: Backward walking training
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Forward walking training
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (routine physiotherapy)
Number of subjects: 65
Study: 25578869

Group type: EXPERIMENTAL
Intervention: Oral metronomic chemotherapy (daily celecoxib 200mg twice daily and weekly methotrexate 15mg/m²)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Intravenous single agent cisplatin (75mg/m² every 3 weeks)
Number of subjects: 110
Study: 24013058

Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg weekly for 26 weeks
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 21903881

Group type: EXPERIMENTAL
Intervention: 2 g cocoa
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 5 g cocoa
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 13 g cocoa
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 26 g cocoa
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (0 g cocoa)
Number of subjects: 23
Study: 19021713

Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction before age 55
Number of subjects: 20187

Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 55-59
Number of subjects: 20187

Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 60-64
Number of subjects: 20187

Group type: EXPERIMENTAL
Intervention: Parental history of myocardial infarction at age 65+
Number of subjects: 20187

Group type: COMPARATOR
Intervention: No parental history of myocardial infarction
Number of subjects: 20187
Study: 17472022

Group type: EXPERIMENTAL
Intervention: perindopril 2 mg + indapamide 0.625 mg
Number of subjects: 216

Group type: COMPARATOR
Intervention: placebo (substituted for perindopril 2 mg + indapamide 0.625 mg)
Number of subjects: 216
Study: 12829659

Group type: EXPERIMENTAL
Intervention: Intensive, individualized diet and exercise intervention
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Both the A allele of the TNF-α gene and the C-174C genotype of the IL-6 gene
Number of subjects: 490

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 490
Study: 10859075

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted sigmoid resection after re-establishing pneumoperitoneum
Number of subjects: 31

Group type: COMPARATOR
Intervention: Laparoscopic-assisted sigmoid resection with anastomosis performed in an open fashion through a horizontal suprapubic incision
Number of subjects: 31
Study: 9169739

Group type: EXPERIMENTAL
Intervention: Bicarbonate-ascorbic acid buffer
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Alka-Seltzer
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: CeraVacx
Number of subjects: 39

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 39
Study: 8460760

Group type: EXPERIMENTAL
Intervention: Diclofenac 1.0 mg.kg‐1
Number of subjects: 198

Group type: COMPARATOR
Intervention: Papaveretum 0.2 mg.kg‐1
Number of subjects: 198
Study: 3958345

Group type: EXPERIMENTAL
Intervention: High pulse repetition frequency Doppler echocardiography
Number of subjects: 125

Group type: COMPARATOR
Intervention: Continuous wave Doppler echocardiography
Number of subjects: 125
Study: 29415163

Group type: EXPERIMENTAL
Intervention: Bromocriptine administration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29540164

Group type: EXPERIMENTAL
Intervention: Clinical exercise efficacy trial for participants with neurologic disability (multiple sclerosis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Home-based teleexercise trial
Number of subjects: 0
Study: 29952453

Group type: EXPERIMENTAL
Intervention: 2% sodium hyaluronate plus 0.5% mannitol
Number of subjects: 20
Study: 24948048

Group type: EXPERIMENTAL
Intervention: Mifepristone (50mg at 0, 12, and 24h, total 150mg) + Ethacridine lactate (100mg)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Ethacridine lactate (100mg) alone
Number of subjects: 276
Study: 21934474

Group type: EXPERIMENTAL
Intervention: Tai Chi Chih (TCC)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 83
Study: 20471178

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitor (letrozole 2.5 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Combination of aromatase inhibitor and estradiol (75 μg/24 h)
Number of subjects: 21
Study: 18805118

Group type: EXPERIMENTAL
Intervention: Moderate aortic stenosis (AS) patients
Number of subjects: 50
Study: 15780145

Group type: EXPERIMENTAL
Intervention: Short-term TTO exercise
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Long-term TTO exercise
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: TTO and CV exercises
Number of subjects: 515
Study: 12432288

Group type: EXPERIMENTAL
Intervention: Stapled anopexy
Number of subjects: 99

Group type: COMPARATOR
Intervention: Open hemorrhoidectomy
Number of subjects: 99
Study: 10478767

Group type: EXPERIMENTAL
Intervention: Advanced color‐coded duplex sonography during cervical rotation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Advanced color‐coded duplex sonography after spinal manipulation therapy
Number of subjects: 20
Study: 8960787

Group type: EXPERIMENTAL
Intervention: 20 mg simvastatin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 1292787

Group type: EXPERIMENTAL
Intervention: Fotemustine (FM) alone on days 1, 8, 15 followed by a 5-week rest period
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fotemustine (FM) administered on days 1 and 8 alternating with Dacarbazine (DTIC) on days 15 and 16, followed by a 5-week rest period
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dacarbazine (DTIC) followed 4 hours later by Fotemustine (FM)
Number of subjects: 24
Study: 2991051

Group type: EXPERIMENTAL
Intervention: High carbohydrate/high fibre/low fat diet (group C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional low carbohydrate diet (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional low carbohydrate diet (group A)
Number of subjects: 40
Study: 31363901

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 94

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 94
Study: 30241119

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBO2) for four weeks in addition to routine therapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional treatment only (Control group)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBO2)
Number of subjects: 98
Study: 26970160

Group type: EXPERIMENTAL
Intervention: MicronJet600 microneedle
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional needle
Number of subjects: 100
Study: 25373872

Group type: EXPERIMENTAL
Intervention: Polyaxial locking plate (NCB®, Zimmer)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Monoaxial locking plate (PERILOC®, Smith & Nephew)
Number of subjects: 14
Study: 23213976

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Zhigou (TE 6) and Zusanli (ST 36)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electroacupuncture at non-acupoint sites
Number of subjects: 40
Study: 19675319

Group type: EXPERIMENTAL
Intervention: Adherence tracking and alert system
Number of subjects: 2293

Group type: COMPARATOR
Intervention: Active medication list alone
Number of subjects: 2293
Study: 18768036

Group type: EXPERIMENTAL
Intervention: Carbohydrate-high-fat snack (30 g CHO, 2 g protein, 20 g fat; 320 kcal)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate-low-fat snack (30 g CHO, 2.5 g protein, 1.3 g fat; 138 kcal)
Number of subjects: 10
Study: 15567456

Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs
Number of subjects: 88
Study: 11880007

Group type: EXPERIMENTAL
Intervention: Monolith DSE (fast release profile)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monolith SDE (slower release profile)
Number of subjects: 0
Study: 12080647

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) - clamping of the main pulmonary artery for 10 minutes followed by 10 minutes of release (Group IP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (C) - no ischemic preconditioning (Group C)
Number of subjects: 20
Study: 7718710

Group type: EXPERIMENTAL
Intervention: Synthetic salmon calcitonin (100 daily I.U. nasally administered) plus 500 mg of calcium per day
Number of subjects: 88

Group type: COMPARATOR
Intervention: Calcium (1 g per day)
Number of subjects: 88
Study: 1786130

Group type: EXPERIMENTAL
Intervention: Continuous Polydioxanone
Number of subjects: 99

Group type: COMPARATOR
Intervention: Interrupted Neurilon
Number of subjects: 99
Study: 6688772

Group type: EXPERIMENTAL
Intervention: Furosemide 0.5 mg/kg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 31847830

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily for 90 days
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 30033617

Group type: COMPARATOR
Intervention: Informative power prior from historical data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New trial data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninformative prior
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early stopping rule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed design methodology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiovascular outcomes trial
Number of subjects: 0
Study: 26955673

Group type: EXPERIMENTAL
Intervention: Compound Tripterygium wilfordii Hook F. (TwHF)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 24768518

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at 0.5 μg/kg/h (LDA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine at 1 μg/kg/h (HDA)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (C) with no dexmedetomidine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (both LDA and HDA)
Number of subjects: 6
Study: 22033349

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) - 1g bolus followed by infusion at 200mg/h
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group - saline infusion
Number of subjects: 76
Study: 20840481

Group type: COMPARATOR
Intervention: Tacrolimus BID (twice-daily)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Tacrolimus QD (once-daily)
Number of subjects: 475
Study: 17978109

Group type: EXPERIMENTAL
Intervention: Empiric antibiotics to reduce chorioamnionitis-related perinatal HIV transmission
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Previous stillbirth
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Antenatal hemorrhage
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Clinical chorioamnionitis
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Marked polymorphonuclear infiltration on placental histology
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Pregnancies at 34-37 weeks
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Pregnancies at less than 34 weeks
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: HIV infection
Number of subjects: 2434

Group type: EXPERIMENTAL
Intervention: Decreasing CD4 cell count among HIV-infected women
Number of subjects: 2434
Study: 16334698

Group type: EXPERIMENTAL
Intervention: High Variability Phonetic Training (natural words from multiple talkers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All Enhancement (F3 contrast maximized and closure duration lengthened)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceptual Fading (F3 enhancement reduced during training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary Cue Variability (variation in F2 and durations increased during training)
Number of subjects: 0